Surgical management of cardiac tamponade: Is left

anterior minithoracotomy really safe and effective? by Mirko Barone* , Marco Prioletta, Giuseppe Cipollone, Decio Di Nu,
Journal of Emergency Practice and Trauma
Introduction
Cardiac tamponade is a life-threatening clinical entity that 
requires an emergency treatment (1). It is characterized 
by hemodynamic abnormalities resulting from an in-
creased pericardial pressure due to the accumulation of 
fluid (serum, blood, chyle, pus) leading to a restriction of 
the filling rate, a reduction in stroke volume and cardiac 
output (2).
Cardiac tamponade can be caused by pericarditis (idio-
pathic, viral), iatrogenic injury (percutaneous procedures, 
post-CABG), thoracic trauma, neoplasms (thoracic and 
extrathoracic ones), uremia, cirrhosis, collagen diseases, 
vasculitis, systemic lupus erythematosus, tuberculosis, 
Dressler syndrome, aortic dissection, oozing ventricular, 
aortic or ventricular blow-out (3). The diagnostic triad of 
cardiac tamponade, or Beck’s triad, is the reduction of ar-
terial blood pressure, increased venous pressure and quiet 
heart (4). Clinical signs of cardiac tamponade include 
hypotension, tachycardia, pulsus paradoxus, increased 
jugular pressure (Kussmaul’s sign), muffled heart sounds, 
decreased ECG voltages and increased cardiac silhouette 
on plain chest radiograph (2).
A variety of methods have been described for the treat-
ment of these cases from needle-guided pericardiocente-
sis (5), balloon-based techniques to surgical pericardioto-
my (6,7), aiming to detention of cardiac compression and 
prevention of re-accumulation (8). 
Surgical techniques are usually associated with a lower risk 
of recurrence, especially in cancer patients. In Literature, 
minimally invasive (video-assisted thoracoscopic pericar-
dial window) and invasive surgical accesses (subxiphoid 
pericardiotomy, pericardiotomy via median sternotomy 
or via left anterior minithoracotomy) (9-11) are described.
Methods
This study involved 61 patients (37 males and 24 females) 
observed from 2010 to 2015 with an average age of 61.80 
± 16.32 years (Table 1). All patients underwent emer-
gency surgery due to the presence of cardiac tamponade. 
Diagnosis was clinical (arterial hypotension, tachycardia, 
dyspnoea, Kussmaul’s sign, pulsus paradoxus) and radio-
graphic (M- and 2D-mode echocardiography, computed 
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Abstract
Objective: Cardiac tamponade is a life-threatening clinical entity that requires an emergency 
treatment. Cardiac tamponade can be caused both by benign and malignant diseases. A 
variety of methods have been described for the treatment of these cases from needle-guided 
pericardiocentesis, balloon-based techniques to surgical pericardiotomy. The Authors report 
their experience in surgical management of cardiac tamponade and an exhaustive review of 
literature. 
Methods: This study involved 61 patients (37 males and 24 females) with an average age of 
61.80 ± 16.32 years. All patients underwent emergency surgery due to the presence of cardiac 
tamponade. 
Results: Cardiac tamponade was caused by a benign disease in 57.40% of patients. In 
cancer patients group, lung cancer, breast cancer and malignant pleural mesothelioma were 
the most common neoplasms (17-27, 87%). The average preoperative size of pericardial 
effusion at M-2D echocardiography was 30.15 ± 5.87 mm. Postoperative complications were 
observed in 11 patients (18%). The reoperation rate was 3.3% (2 patients) due to relapsed 
cardiac tamponade. 30-day mortality rate was 3.3%. Overall cumulative survival was 29.9 
± 20.1 months. Twenty-nine patients (47.5%) died during the follow up period. By dividing 
the population into two groups, group B (benign) and group M (malignant), there was a 
statistically significant difference (P < 0.001) in terms of survival. 
Conclusion: In conclusions, anterior minithoracotomy for surgical treatment of cardiac 
tamponade has to be held into account in patients both with benign diseases and 
malignancies.
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tomography (CT) angiography of the chest). In our de-
partment, all patients undergo a preoperative CT angiog-
raphy of the chest in order to exclude any myocardical or 
aortic bulb injury (ventricular blow out or oozing, lacera-
tions of the coronary vessels). In fact, in the presence of 
these lesions, patient management is entrusted to cardiac 
surgeons. 
All patients underwent routine blood chemistry and 
blood gas analysis in order to complete diagnostic iter. 
On account of the emergency, all patients with pericar-
dial effusion with hemodynamic impairment were quickly 
sent for surgery, a pleuro-pericardial window. The surgi-
cal technique involves a 4-6 cm left anterior minithora-
cotomy at the fourth intercostal space with patient in 45 
degrees left lateral decubitus position. The angle allows a 
better exposure of the pericardial sac. After opening the 
pleural cavity, an intrapleural pericardiotomy ahead the 
left phrenic nerve is done, allowing a gradual and cautious 
detension of the pericardial sac. At the end of the pericar-
dial drainage, a 3 × 3 cm piece of serous is picked up. The 
rationale is to perform a histological analysis of tissue and 
to pack an effective means between the pericardium and 
the left mediastinal pleura. After surgery, a chest drainage 
is placed. The average time of the intervention was 36 ± 
21 minutes.
All data are presented as means with standard deviations 
and their minimum and maximum values. Categorical 
variables are presented as absolute (N) and percentage 
(%). The analysis of survival was performed with the use 
of Kaplan and Meier’s method with relative curves. These 
were compared with the method of logarithmic regres-
sion. P values less than 0.05 were considered statistically 
significant. 
Results
On admission, the cause of cardiac tamponade was un-
known in most of patients (33-54, 10%). In two patients, 
cardiac tamponade was the first sign of an unknown met-
astatic tumor disease (lung adenocarcinoma and cardiac 
lymphoma). In the remaining cases, cardiac tamponade 
was secondary to the presence of a tumor within or out-
side the chest (one patient with metastatic carcinoma of 
the penis) or to a thoracic trauma (3-4, 92%).
Histologically, a benign disease was the cause of cardiac 
tamponade in 57.40% of patients (35 patients), such as 
refractory pericarditis (26-43, 33%), hydropericardium 
from decompensated cirrhosis or chronic renal insuffi-
ciency. In cancer patients group, lung cancer, breast cancer 
and malignant pleural mesothelioma were the most com-
mon neoplasms (17-27, 87%). Also, mediastinal tumors 
(thymoma, lymphoma, synovial sarcoma) may cause sec-
ondary cardiac tamponade (Table 2).
The average preoperative size of the pericardial effusion 
at M-2D echocardiography was 30.15 ± 5.87 mm. How-
ever, the amount of pericardial effusion can not be cor-
related to the onset of cardiac tamponade; in fact, in our 
experience, we have seen cases of conspicuous pericardial 
effusion without hemodynamic impairment due to the 
onset of compensatory mechanisms such as pulmonary 
hypertension. The average hospital stay of the patients was 
14.5 ± 9.6 days. The reason is to be found in patients’ co-
morbidities and post-operative controls. In fact, all were 
echocardiographically screened (average postoperative 
pericardial effusion thickness: 3.8 ± 5.4 mm) and only, 
in the presence of resolution of the pericardial effusion, 
chest tube was removed (average time: 10.4 ± 6.4 days) 
(Table 1).
Postoperative complications were observed in 18% of 
Table 1. General population characteristics
Drugs No. Percent 
Sex
Male 37 60.70
Female 24 39.30
Age 61.80 (18-94)
Hospital stay 14.5 ± 9.6 (6-60)
Preoperative fluid collection width 30.15 ± 5.87 (18.00-42.00)
Postoperative fluid collection 
width
3.8 ± 5.4 (0.00-33.00)
Chest drain permanence 10.4 ± 6.4 (4.00-45-00)
Complicationsa 11 18.00
Re-do surgery 2 3.30
Perioperative death 2 3.30
Cumulative OSb 29.90 ± 20.10 (0.00-67.00)
Group B 58.4 ± 2.88
Group M 15.94 ± 2.93
Death 29 47.5
Disease-related death 22 36.1
a 4 patients atrial fibrillation, 2 patients ventricular fibrillation, 2 
patients relapsed cardiac tamponade, 2 patients respiratory failure, 1 
patient anemia.
b P < 0.001.
Table 2. Cardiac tamponade etiology
No. Percent
Etiology
Benign 35 57.40
Malignant 26 42.60
Disease
Chronic pericarditis 12 19.70
Pulmonary adenocarcinoma 6 9.80
Pulmonary squamous carcinoma 5 8.20
Breast cancer 3 4.90
Malignant pleural mesothelioma 3 4.90
Hydropericardium 5 8.20
Cardiac lymphoma 1 1.60
Non Hodgkin lymphoma 3 4.90
Penis cancer 1 1.60
Acute pericarditis 14 23.00
Thymoma 3 4.90
Thoracic trauma 3 4.90
Synovial sarcoma 1 1.60
Chylopericardium 1 1.60
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patients (11 patients). Most cases were cardiac complica-
tions (atrial fibrillation, ventricular fibrillation, relapsed 
cardiac tamponade). Two cases of respiratory failure and 
one of anemia were also recorded. In our experience, there 
was no mention of post-operative cardiac herniations sec-
ondary to the pericardial window procedure.
The reoperation rate was 3.3% (2 patients) due to relapsed 
cardiac tamponade. In one case, the second surgical access 
was a median sternotomy.
Although packing a pleuro-pericardial window represents 
a surgical emergency, the 30-day mortality rate was only 
3.3% (2 patients). 
All patients observed from 2010 to 2015 were subjected to 
follow-up. Overall cumulative survival of the general pop-
ulation was 29.90 ± 20.10 months. Twenty-nine patients 
(47.5%) died during the follow up period. In 22 (75.87%) 
of these, death was due to the same disease causing the 
episode of cardiac tamponade. By dividing the popula-
tion into two groups, group B (benign) and group M 
(malignant) there was a statistically significant difference 
(P < 0.001) in terms of survival. In fact, an average of 58.4 
± 2.88 (95% CI: 52.72 to 64.04) months was reported for 
group B patients and an average of 15.94 ± 2.93 (95% CI: 
33.96 to 47.96) months for group M patients, respectively 
(Figure 1). This discrepancy is mainly due to the etiology 
of cardiac tamponade. In cancer patients, this hemody-
namic manifestation could be the evolution of metastatic 
disease characterized by a poor and a dismal prognosis.
Discussion
Cardiac tamponade is a life-threatening clinical entity that 
may result in a rapidly fatal cardiogenic shock (1). Presen-
tation of cardiac tamponade can range from a minimally 
symptomatic effusion to a state of complete cardiovascu-
lar decompensation. In fact, it may be silent (echocardio-
graphic tamponade), may present with classic symptoms, 
Beck’s triad (4) (clinical tamponade), or may be the cause 
of a hemodynamic collapse (terminal tamponade). The 
first two represent the most common conditions and, as 
reported by Tsang et al, they reach a percentage higher 
than 90% (5). Cardiac tamponade is associated with 
widespread low electrocardiographic voltages (12) due 
to changes in the electro-mechanical pulse and diffusion 
abnormalities of body impedance (13). These findings 
(low QRS complexes) recover up to 81% of cases (14,15) 
(Figure 2). Echocardiography is the main diagnostic test 
for the diagnosis of cardiac tamponade. The examination, 
performed in M- and 2D-mode, allows to evaluate the ef-
fusion thickness, the cardiac kinesis and indirect signs of 
hemodynamic dysfunction (Figure 3).
Cardiac tamponade can be caused by pericarditis (idio-
pathic, viral), iatrogenic injury (percutaneous procedures, 
post-CABG), thoracic trauma, neoplasms (thoracic and 
extrathoracic ones), uremia, cirrhosis, collagen diseases, 
chilopericardium (16), vasculitis, systemic lupus ery-
thematosus (17), tuberculosis, hypothyroidism (18,19), 
Dressler syndrome, aortic or coronaric dissection (20), 
ventricular oozing, aortic or ventricular blow-out (3).
Figure 1. Probability of survival after cardiac tamponade (group B vs. 
group M).
Figure 2. Cardiac tamponade: ECG findings (our personal case).
Figure 3. Cardiac tamponade: Echocardiographic findings (our 
personal case).
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Allen et al (21), in a series of patients with cardiac tam-
ponade, reported that more than 60% of the cases were 
from cancer, while the remaining from inflammatory pro-
cesses and uremic states.
In our study, data seem to be in slight contrast. In fact, 
57.40% of cases were due to benign diseases (chronic or 
acute refractory pericarditis), while the remainings from 
neoplasms. Among these latters, lung cancer (squamous 
cell carcinoma and adenocarcinoma) was the predomi-
nant one (18.0%), followed by malignant pleural mesothe-
lioma, breast cancer and mediastinal tumors.
However, our results are confident with Literature, since 
more than half of secondary neoplasms of the pericardi-
um are to be referred to lung cancer and breast cancer. The 
actual incidence of pericardial and myocardial metastatic 
diseases varies between 1% and 18% of all cancers (22).
Pericardial effusions are less common than pleural ones 
in cancer patients; although, their acute onset may rapidly 
deteriorate clinical conditions and significantly influence 
on prognosis.
Cardiac tamponade is a hemodynamic emergency that 
requires a rapid and timely intervention. But what is the 
gold standard of treatment is a discussed issue today. A 
variety of methods have been described from the needle-
guided pericardiocentesis (5), balloon-based techniques 
to surgical pericardiotomy (6,7).
Needle-guided pericardiocentesis, considered the stan-
dard of treatment, is a rapid method for drainage. It may 
be adopted in hemodynamically unstable patients, in in-
tensive care units or in patients who are unsuitable for 
surgery due to poor clinical conditions. It is well-tolerated 
in all age groups, including children (23), and it can be 
quickly performed in unstable patients to relieve symp-
toms (24). Moreover, it presents low mortality, low com-
plications, but high recurrence rates.
Pericardiocentesis is life-saving and it is indicated for 20 
mm or more effusions (diastolic width). The most dan-
gerous complications are myocardial or coronaric lacera-
tions but safety has been implemented with the adoption 
of echocardiographic or fluoroscopic guidance.
Maisch et al (25), in the European Society of Cardiology 
guidelines, reported major complication rates of about 
1.3%-1.6%. Among these, cardiac perforations (0.9%) and 
arrhythmias (0.6%) are the most recurrent. Minor com-
plications include pneumothorax, vasovagal response 
with transient hypotension, non-sustained supraven-
tricular tachycardia and pleuropericardial fistula (5,26). 
Procedure-related mortality is low (<1%), while overall 
complications may vary from 4% to 20% (27,28). At the 
same time, Kopecky et al (29) and Celermajer et al (30) re-
ported recurrence rates ranging from 19% to 24%. Finally, 
the procedure also allows to leave pericardial indwelling 
catheters for drainage or for locoregional chemotherapy 
(31-33).
Surgical procedures for pericardial drainage are: subxifoid 
pericardial window, transthoracic pericardial window (left 
anterior submammary minithoracotomy) and pericardi-
otomy via median sternotomy. The potential advantages 
of a surgical approach are direct visualization, exploration 
of the entire pericardium, a complete drainage, biopsy 
of the pericardium for histological examination and the 
placement of a larger caliber drainage (34,35). 
Subxifoid pericardial window is simple and reproducible 
(36). Kurimoto et al (37) also proposed the opportunity to 
perform a blind finger-assisted subxifoid pericardiotomy, 
highlighting the good efficacy of the procedure.
Video-assisted thoracoscopic pericardial window has 
many advantages: minor trauma, the ability to perform 
wider pericardial resections, the best visualization of ana-
tomical structures and the possibility of posterior pericar-
dial collection drainage (38). Muhammad (39) reported 
no intra and postoperative complications and mortality. 
Also, Georghiou et al (40) described no peri-procedural 
complications, but video-assisted surgery is still contra-
indicated in patients with impaired respiratory function 
contraindicating single-lung ventilation (9). In addition, 
pediatric cases with thoracoscopic access have been de-
scribed (41,42). A modified video-assisted thoracoscopy 
technique was described by Monaco et al (43).
The creation of a pericardial window (subxifoid or trans-
thoracic) is preferable in cancer patients in order to allow 
a permanent drainage. Our choice to perform a trans-
thoracic pericardial window through a minithoracotomy 
finds comfort with papers in Literature. Olsen et al (44) 
believe the procedure is quick and simple. No cases of 
intra- or postoperative deaths are reported. Gregory et al 
(45), however, reported a mortality rate of 8%. Transtho-
racic surgery is rapid and it does not require a selective 
pulmonary intubation (Carlens’ or Robertshaw’s tube), 
as opposed for video thoracoscopic access, which could 
lead to the onset of a hemodynamic overload or a tachyar-
rhythmia due to selective intubation. In our study, we ob-
served an overall mortality rate of 3.3% (one case of car-
diac lymphoma and one case of malignant pleural meso-
thelioma); eithers due to the onset of electro-mechanical 
cardiac complications (ventricular fibrillation). Morbidity 
rate of 11.74% (7/11) in cancer patients. Celik et al (46) 
reported a median overall survival of 10.41 ± 1.79 months 
for cancer patients, while in our study we observed a sur-
vival rate of 15.94 ± 3.86. In addition, we observed a low 
recurrence rate (3.3%), one in a cancer patient, and this 
data is significantly lower than those reported in literature 
both for pericardiocentesis and surgical cases. Regard-
ing these cases, we believe the origin is to be found in the 
rapid establishment of post surgical adhesions leading to 
an altered drainage and therefore a failure of the pericar-
dial window. Both episodes occurred within 30 days after 
surgery suggesting the onset of a post pericardiotomy syn-
drome. This clinical entity is classified as a specific form 
of iatrogenic or traumatic pericarditis and it is character-
ized by recurrent post surgical pericardial effusion. The 
syndrome is usually self-limited and it presents a variable 
incidence from 1% to 17.8% (47,48). Nishimura et al be-
lieve that causes are due to immune factors interfering 
with host response (49).
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Conclusion
In conclusion, we believe the transthoracic surgical treat-
ment of cardiac tamponade has to be held into account 
in patients both with benign diseases and malignancies. 
Our results, in terms of perioperative morbidity and mor-
tality, are quite comparable to patients undergoing mini-
mally invasive or percutaneous procedures. Moreover, low 
mortality and recurrence rates demonstrate pericardial 
window via anterior minithoracotomy can be considered 
a safe and effective method in the treatment of cardiac 
tamponade.
Authors’ contributions 
All authors contributed to data collection, text arrange-
ment and study design.
Ethical issues 
The article does not contain any research with human par-
ticipants performed by the authors. For this type of study, 
no formal consent was required. It is an anonymous one.
References
1. Sagristà-Sauleda J, Mercé AS, Soler-Soler J. Diagnosis and 
management of pericardial effusion. World J Cardiol 2011; 
3(5): 135-43. doi: 10.4330/wjc.v3.i5.135.
2. Seferović PM, Ristić AD, Imazio M, Maksimović R, 
Simeunović D, Trinchero R, et al. Management strategies 
in pericardial emergencies. Herz 2006; 31(9): 891-900. doi: 
10.1007/s00059-006-2937-0.
3. LeWinter MM, Tischler MD. Pericardial diseases. In: 
Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald’s 
Heart Disease: A Textbook of Cardiovascular Medicine. 9th 
ed. Philadlephia, PA: Saunders Elsevier; 2011. 
4. Beck CS. Two cardiac compression triads. JAMA 1935; 104 
(9): 714-6. doi: 10.1001/jama.1935.02760090018005.
5. Tsang TS, Enriquez-Sarano M, Freeman WK, Barnes ME, 
Sinak LJ, Gersh BJ, et al. Consecutive 1127 therapeutic 
echocardiographically guided pericardiocenteses: clinical 
profile, practice patterns, and outcomes spanning 21 years. 
Mayo Clin Proc 2002; 77(5): 429-36. doi: 10.4065/77.5.429.
6. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of 
malignant pericardial effusion. JAMA 1994; 272(1): 59-64. 
doi: 10.4065/77.5.429.
7. Swanson N, Mirza I, Wijesinghe N, Devlin G. Primary 
percutaneous balloon pericardiotomy for malignant 
pericardial effusion. Catheter Cardiovasc Interv 2008; 
71(4): 504-7. doi: 10.1002/ccd.21431.
8. Mercé J, Sagristà-Sauleda J, Permanyer-Miralda G, Soler-
Soler J. Should pericardial drainage be performed routinely 
in patients who have a large pericardial effusion without 
tamponade? Am J Med 1998; 105(2): 106-9. doi: 10.1016/
s0002-9343(98)00192-2.
9. Georghiou GP, Stamler A, Sharoni E, Fichman-Horn S, 
Berman M, Vidne BA, et al. Video-assisted thoracoscopic 
pericardial window for diagnosis and management of 
pericardial effusions. Ann Thorac Surg 2005; 80(2): 607-10. 
doi: 10.1016/j.athoracsur.2005.02.068.
10. Fortuño Andrés JR, Alguersuari Cabiscol A, Falcó Fages J, 
Castañer González E, Bermudez Bencerrey P. Radiological 
approach to cardiac tamponade. Radiologia 2010; 52(5): 
414-24. doi: 10.1016/j.rx.2010.05.011. [In Spanish].
11. Liberman M, Labos C, Sampalis JS, Sheiner NM, Mulder 
DS. Ten-year surgical experience with nontraumatic 
pericardial effusions: a comparison between the subxyphoid 
and transthoracic approaches to pericardial window. Arch 
Surg 2005; 140(2): 191-5. doi: 10.1001/archsurg.140.2.191.
12. Eisenberg MJ, de Romeral LM, Heidenreich PA, Schiller 
NB, Evans GT Jr. The diagnosis of pericardial effusion 
and cardiac tamponade by 12-lead ECG. A technology 
assessment. Chest 1996; 110(2): 318-24. doi: 10.1378/
chest.110.2.318.
13. Karatay CM, Fruehan CT, Lighty GW Jr, Spear RM, 
Smulyan H. Acute pericardial distension in pigs: effect of 
fluid conductance on body surface electrocardiogram QRS 
size. Cardiovasc Res 1993; 27(6): 1033-8. doi: 10.1093/
cvr/27.6.1033.
14. Bruch C, Schmermund A, Dagres N, Bartel T, Caspari 
G, Sack S, et al. Changes in QRS voltage in cardiac 
tamponade and pericardial effusion: reversibility after 
pericardiocentesis and after anti-inflammatory drug 
treatment. J Am Coll Cardiol 2001; 38(1): 219-26. doi: 
10.1016/s0735-1097(01)01313-4.
15. Gumrukcuoglu HA, Odabasi D, Akdag S, Ekim H. 
Management of cardiac tamponade: a comperative study 
between echo-guided pericardiocentesis and surgery-a 
report of 100 patients. Cardiol Res Pract 2011; 2011: 
197838. doi: 10.4061/2011/197838. 
16. Barbetakis N, Asteriou C, Konstantinou D, Giannoglou 
D, Tsilikas C, Giannoglou G. Spontaneous chylous cardiac 
tamponade: a case report. J Cardiothorac Surg 2010; 5: 11. 
doi: 10.1186/1749-8090-5-11.
17. Maharaj SS, Chang SM. Cardiac tamponade as the initial 
presentation of systemic lupus erythematosus: a case report 
and review of the literature. Pediatr Rheumatol Online J 
2015; 13: 9. doi: 10.1186/s12969-015-0005-0. 
18. Hellmann AR, Kostro J, Dziedzic R, Hellmann M, Dudziak 
M. Cardiac tamponade as the first manifestation of primary 
hypothyroidism. Kardiol Pol 2015; 73(9): 786. doi: 10.5603/
kp.2015.0168.
19. Sinha A, Yeruva SL, Kumar R, Curry BH. Early 
cardiac tamponade in a patient with postsurgical 
hypothyroidism. Case Rep Cardiol 2015; 2015: 310350. doi: 
10.1155/2015/310350. 
20. Goh AC, Lundstrom RJ. Spontaneous coronary artery 
dissection with cardiac tamponade. Tex Heart Inst J  2015; 
42(5): 479-82. doi: 10.14503/THIJ-14-4260. 
21. Allen KB, Faber LP, Warren WH, Shaar CJ. Pericardial 
effusion: subxiphoid pericardiostomy versus percutaneous 
catheter drainage. Ann Thorac Surg 1999; 67(2): 437-40. 
doi: 10.1016/s0003-4975(98)01192-8.
22. Gassman HS, Meadows R, Baker LA. Metastatic tumors of 
the heart. Am J Med 1955; 19(3): 357-65. doi:10.1016/0002-
9343(55)90124-8.
23. Tsang TS, El-Najdawi EK, Seward JB, Hagler DJ, Freeman 
WK, O’Leary PW. Percutaneous echocardiographically 
guided pericardiocentesis in pediatric patients: evaluation 
of safety and efficacy. J Am Soc Echocardiogr 1998; 11(11): 
1072-7. doi: 10.1016/s0894-7317(98)70159-2.
24. Fitch MT, Nicks BA, Pariyadath M, McGinnis HD, 
Manthey DE. Videos in clinical medicine. Emergency 
pericardiocentesis. N Engl J Med 2012; 366(12): e17. doi: 
10.1056/nejmvcm0907841.
25. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, 
Adler Y, et al. Guidelines on the diagnosis and management 
Barone et al
Journal of Emergency Practice and Trauma, 2017, 3(2), 53-5858
of pericardial diseases executive summary; The Task force 
on the diagnosis and management of pericardial diseases of 
the European society of cardiology. Eur Heart J 2004; 25(7): 
587-610. doi: 10.1016/j.ehj.2004.02.002.
26. Wong B, Murphy J, Chang CJ, Hassenein K, Dunn M. The 
risk of pericardiocentesis. Am J Cardiol 1979; 44(6): 1110–
4.
27. Ainsworth CD, Salehian O. Echo-guided pericardiocentesis: 
Let the bubbles show the way. Circulation 2011; 123(4): 
e210–1. doi: 10.1161/circulationaha.110.005512.
28. Fejka M, Dixon SR, Safian RD, O’Neill WW, Grines CL, 
Finta B, et al. Diagnosis, management, and clinical outcome 
of cardiac tamponade complicating percutaneous coronary 
intervention. Am J Cardiol 2002; 90(11): 1183-6. doi: 
10.1016/s0002-9149(02)02831-x.
29. Kopecky SL, Callahan JA, Tajik AJ, Seward JB. Percutaneous 
pericardial catheter drainage: report of 42 consecutive 
cases. Am J Cardiol 1986; 58(7): 633-5. doi: 10.1016/0002-
9149(86)90290-0.
30. Celermajer DS, Boyer MJ, Bailey BP, Tattersall MH. 
Pericardiocentesis for symptomatic malignant pericardial 
effusion: a study of 36 patients. Med J Aust 1991; 154(1): 
19-22.
31. Tanaka Y, Tsuboi K, Yamamoto A, Tsuda S, Tsujii S, Yagi 
K, et al. Long-term survival of a breast cancer patient 
with carcinomatous pleuritis and carcinomatous cardiac 
tamponade successfully treated by multimodality therapy. 
Gan To Kagaku Ryoho 2015; 42(4): 489-92. [In Japanese].
32. Lestuzzi C, Berretta M, Tomkowski W. 2015 update on 
the diagnosis and management of neoplastic pericardial 
disease. Expert Rev Cardiovasc Ther 2015; 13(4): 377-89. 
doi: 10.1586/14779072.2015.1025754.
33. Sun T, Zhang Y, Shen Y, Hu K, Zuo M. A case of advanced 
lung cancer with malignant pericardial effusion treated by 
intrapericardial Cinobufacini injection instillation. Biosci 
Trends 2014; 8(4): 235-9. doi: 10.5582/bst.2014.01073.
34. McDonald JM, Meyers BF, Guthrie TJ, Battafarano RJ, 
Cooper JD, Patterson GA. Comparison of open subxiphoid 
pericardial drainage with percutaneous catheter drainage 
for symptomatic pericardial effusion. Ann Thorac Surg 
2003; 76(3): 811-5. doi: 10.1016/s0003-4975(03)00665-9.
35. Buchanan CL, Sullivan VV, Lampman R, Kulkarni MG. 
Pericardiocentesis with extended catheter drainage: an 
effective therapy. Ann Thorac Surg 2003; 76(3): 817-20. doi: 
10.1016/s0003-4975(03)00666-0
36. Watarida S, Shiraishi S, Matsubayashi K, Imura M, Nishi 
T. Pericardial-peritoneal window for chronic exudative 
pericarditis using a subxiphoidal approach: report of 
three cases. Surg Today 2002; 32(5): 410-3. doi: 10.1007/
s005950200064.
37. Kurimoto Y, Hase M, Nara S, Yama N, Kawaharada N, 
Morishita K, et al. Blind subxiphoid pericardiotomy for 
cardiac tamponade because of acute hemopericardium. 
J Trauma 2006; 61(3): 582-5. doi: 10.1097/01.
ta.0000236060.37952.ce
38. Uramoto H, Hanagiri T. Video-assisted thoracoscopic 
pericardiectomy for malignant pericardial effusion. 
Anticancer Res 2010; 30(11): 4691-4.
39. Muhammad MI. The pericardial window: is a video-
assisted thoracoscopy approach better than a surgical 
approach? Interact Cardiovasc Thorac Surg 2011; 12(2): 
174-8. doi: 10.1510/icvts.2010.243725. 
40. Georghiou GP, Porat E, Fuks A, Vidne BA, Saute M. Video-
assisted pericardial fenestration for effusions after cardiac 
surgery. Asian Cardiovasc Thorac Ann 2009; 17(5): 480-2. 
doi: 10.1177/0218492309348505.
41. Pérez-Etchepare E, Al Makki A, Varlet F, López M. 
Thoracoscopic treatment in pericardial tamponade. Cir 
Pediatr.2012; 25(3): 166-8.
42. Agrawal V, Saxena A, Sethi A, Acharya H, Sharma D. 
Thoracoscopic pericardiotomy for management of purulent 
pneumococcal pericarditis in a child. Asian J Endosc Surg 
2012; 5(3): 145-8. doi: 10.1111/j.1758-5910.2011.00129.x.
43. Monaco F, Barone M, David A, Risitano DC, Lentini 
S. Cardiac tamponade: a modified video-assisted 
thoracoscopic approach. Chir Ital 2009; 61(3): 321-6. [In 
Italian].
44. Olsen PS, Sørensen C, Andersen HO. Surgical treatment 
of large pericardial effusions. Etiology and long-term 
survival. Eur J Cardiothorac Surg 1991; 5(8): 430-2. doi: 
10.1016/1010-7940(91)90189-q.
45. Gregory JR, McMurtrey MJ, Mountain CF. A surgical 
approach to the treatment of pericardial effusion in cancer 
patients. Am J Clin Oncol 1985; 8(4): 319-23.
46. Celik S, Celik M, Aydemir B, Tanrıkulu H, Okay T, Tanrikulu 
N. Surgical properties and survival of a pericardial window 
via left minithoracotomy for benign and malignant 
pericardial tamponade in cancer patients. World J Surg 
Oncol 2012; 10: 123. doi: 10.1186/1477-7819-10-123.
47. Kuvin JT, Harati NA, Pandian NG, Bojar RM, Khabbaz KR. 
Postoperative cardiac tamponade in the modern surgical 
era. Ann Thorac Surg 2002; 74(4): 1148-53. doi: 10.1016/
s0003-4975(02)03837-7.
48. Miller RH, Horneffer PJ, Gardner TJ, Rykiel MF, Pearson TA. 
The epidemiology of the postpericardiotomy syndrome: a 
common complication of cardiac surgery. Am Heart J 1988; 
116(5 Pt 1): 1323-9. doi: 10.1016/0002-8703(88)90457-7.
49. Nishimura RA, Fuster V, Burgert SL, Puga FJ. 
Clinical features and long-term natural history of the 
postpericardiotomy syndrome. Int J Cardiol 1983; 4(4): 
443-50. doi: 10.1016/0167-5273(83)90194-8.
